Skip to main content

Filana Therapeutics, Inc.

FLNA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001069530

In the last 90 days, Filana Therapeutics, Inc. insiders filed 2 open-market purchases and 0 sales; 85 institutions reported holding it in 13F filings for Q2 2026, worth $15.1M in total; no superinvestor holds it.

13F holders, Q4 2021

Institutional positions in Filana Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
171
−7 vs. Q3 2021
Shares held
11.5M
−633.4K (−5.2%) vs. Q3 2021
Total value
$504.1M
−$252.9M (−33.4%) vs. Q3 2021
New holders
34
57 more added
Sold out
41
52 more reduced

3 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting FLNA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2021: 171 institutions
Q1 2021: 128 institutionsQ2 2021: 169 institutionsQ3 2021: 181 institutionsQ4 2021: 171 institutionsQ1 2022: 163 institutionsQ2 2022: 149 institutionsQ3 2022: 174 institutionsQ4 2022: 153 institutionsQ1 2023: 145 institutionsQ2 2023: 152 institutionsQ3 2023: 141 institutionsQ4 2023: 153 institutionsQ1 2024: 142 institutionsQ2 2024: 145 institutionsQ3 2024: 161 institutionsQ4 2024: 137 institutionsQ1 2025: 117 institutionsQ2 2025: 97 institutionsQ3 2025: 103 institutionsQ4 2025: 107 institutionsQ1 2026: 101 institutionsQ2 2026: 85 institutions
Value heldQ4 2021: $504.1M
Q1 2021: $458.2MQ2 2021: $893.4MQ3 2021: $757.3MQ4 2021: $504.1MQ1 2022: $390.2MQ2 2022: $279.2MQ3 2022: $438.9MQ4 2022: $332.5MQ1 2023: $287.9MQ2 2023: $286.8MQ3 2023: $215.4MQ4 2023: $313.5MQ1 2024: $235.3MQ2 2024: $164.6MQ3 2024: $412.5MQ4 2024: $41.1MQ1 2025: $23.6MQ2 2025: $22.1MQ3 2025: $40.1MQ4 2025: $27.3MQ1 2026: $23.1MQ2 2026: $15.1M
Institutions holding FLNA and their total value by quarter
QuarterHoldersValue
Q2 202685$15.1M
Q1 2026101$23.1M
Q4 2025107$27.3M
Q3 2025103$40.1M
Q2 202597$22.1M
Q1 2025117$23.6M
Q4 2024137$41.1M
Q3 2024161$412.5M
Q2 2024145$164.6M
Q1 2024142$235.3M
Q4 2023153$313.5M
Q3 2023141$215.4M
Q2 2023152$286.8M
Q1 2023145$287.9M
Q4 2022153$332.5M
Q3 2022174$438.9M
Q2 2022149$279.2M
Q1 2022163$390.2M
Q4 2021171$504.1M
Q3 2021181$757.3M
Q2 2021169$893.4M
Q1 2021128$458.2M

Institutions, Q4 2021

Shares, value and share of portfolio for each institution holding Filana Therapeutics, Inc.; share changes are against Q3 2021.

Institutions holding FLNA in Q4 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Equitec Proprietary Markets, LLC0$00.00%−1,900−100.0%Sold out
Meeder Asset Management Inc0$00.00%−1,899−100.0%Sold out
O'Shaughnessy Asset Management, LLC0$00.00%−493−100.0%Sold out
Sandy Spring Bank0$00.00%−500−100.0%Sold out
Global Retirement Partners, LLC0$00.00%−500−100.0%Sold out
Anchor Investment Management, LLC0$00.00%−185−100.0%Sold out
Capital Advisory Group Advisory Services, LLC0$00.00%−125−100.0%Sold out
Larson Financial Group LLC0$00.00%−42−100.0%Sold out
Pacitti Group Inc.0$00.00%−40−100.0%Sold out
Meridian Wealth Partners, LLC0$00.00%−13−100.0%Sold out
Carmichael Hill & Associates, Inc.0$00.00%−6−100.0%Sold out
Graves-Light Private Wealth Management, Inc.0$00.00%−4−100.0%Sold out
BFT Financial Group, LLC––––Not filed
Berman Capital Advisors, LLC––––Not filed
Heritage Wealth Management, LLC––––Not filed